Indeed, the angiogenic factor vascular endothelial growth factor-A (VEGF-A) is highly expressed both in tumor and urine samples of bladder cancer patients and correlates with poor prognosis, being associated with progression and tumor recurrence [21]. Here, VEGFA is linked to neoplasm.